Navigation Links
Calibr and JDRF Partner to Support Diabetes Translational Research
Date:3/25/2013

LA JOLLA, Calif., March 25, 2013 /PRNewswire-USNewswire/ -- The California Institute for Biomedical Research (Calibr) and JDRF announced a partnership today to apply Calibr's drug discovery expertise to type 1 diabetes research projects in collaboration with academic investigators from JDRF's network. Termed the Translational Academic Research Partnership, the jointly funded Calibr-JDRF program will establish collaborative projects focused on promising type 1 diabetes therapeutic targets and the discovery of early drug leads for validation and follow-on development.  The initial collaborative projects will be seeded by leading academic investigators working in the area of beta cell biology. Calibr's Matt Tremblay explained the rationale, "The idea is to team up Calibr's chemical and high-throughput screening technologies with the beta cell experts from JDRF's network to validate targets and create new drug discovery programs in areas of novel biology."  The first year of the program will focus on promoting survival of pancreatic beta cells as an approach to restoring blood glucose control in type 1 diabetic patients.

About JDRF

JDRF is the leading global organization funding type 1 diabetes (T1D) research. JDRF's goal is to progressively remove the impact of T1D from people's lives until we achieve a world without T1D. JDRF collaborates with a wide spectrum of partners and is the only organization with the scientific resources, regulatory influence, and a working plan to better treat, prevent, and eventually cure T1D.

As the largest charitable supporter of T1D research, JDRF is currently sponsoring $530 million in scientific research in 17 countries. In 2012 alone, JDRF provided more than $110 million to T1D research. More than 80 percent of JDRF's expenditures directly support research and research-related education. In 2012 Forbes magazine named JDRF one of its five All-Star charities, citing the organization's efficiency and effectiveness.

For more information, please visit www.jdrf.org.   

About Calibr: The California Institute for Biomedical Research (Calibr) is an independent, not-for-profit organization established to accelerate the translation of basic biomedical research to innovative new medicines. The Institute partners with academic scientists around the world to translate research discoveries and new technologies into innovative new therapies for unmet medical needs. Calibr is led by Peter G. Schultz , Ph.D., a world-renowned chemist, biotechnology entrepreneur and Professor of Chemistry at The Scripps Research Institute in San Diego, CA. Located in San Diego, Calibr is housed in newly built labs located near The Scripps Research Institute, The Salk Institute for Biological Studies, the University of California, San Diego and Sanford-Burnham Medical Research Institute.

Contact:
The California Institute for Biomedical Research (Calibr)
Amit Bhatia
VP of Finance & Operations
T: +1-858-242-1000
F: +1-858-242-1001 
abhatia@calibr.org


'/>"/>
SOURCE The California Institute for Biomedical Research
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. Fluke Calibration 9190A Ultra-Cool Field Metrology Well delivers best-in-class stability
2. Masy Systems Now NVLAP Accredited To Perform RH Calibrations
3. NSG Precision Has Perfected the Wavelength Accuracy Calibration Standard
4. NSG Precision Cells’ WAV-7 Didymium Standard Makes Calibrating Wavelength Accuracy a Snap
5. The WAV-1 UV/VIS Holmium Oxide Calibration Standard by NSG Precision Stands Alone Above the Competition
6. NSG Precision Leads Industry with Solid-State Nano-Deposition Calibration Standards
7. RoviSys Partners with POMS MES to Expand Life Sciences Capabilities
8. TaxOps Announces Partner Appointment to Prominent International Position with Fortune 100 Company
9. NineSigma Announces Winners in $25,000 Sustainable Packaging Challenge in Conjunction With Scientists Without Borders and Partners
10. Accelrys Announces Strategic Partnership with USDM
11. MedCity News and UBM Medica US Partner in Distribution of Health IT News
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/5/2016)...  Renova™ Therapeutics, a biotechnology company developing gene ... chronic diseases, announced that Catherine Bovenizer , ... Officer (CFO), effective today. Ms. Bovenizer ... in financial management for a variety of public ... recently, Ms. Bovenizer was the Vice President of ...
(Date:12/5/2016)... , Dec 5, 2016 Research and ... "DNA Sequencing - Technologies, Markets and Companies" to ... , ... briefly reviews basics of human genome variations, development of sequencing ... described as well as companies developing them. Various applications of ...
(Date:12/4/2016)... , Dec. 3, 2016  In five studies ... Hematology (ASH) Annual Meeting and Exposition in ... engineering methods to improve the delivery of life-saving treatments ... new methods are designed to carry therapies directly to ... most, which could provide a substantial advantage over traditional, ...
(Date:12/2/2016)... -- The Multiple Myeloma Research Foundation (MMRF) today announced that ... —the largest and most comprehensive study driving new genomic ... presented at the 58 th American Society of ... San Diego from December 3-6. The new ... as identify pathways and targets for new drug development. ...
Breaking Biology Technology:
(Date:11/15/2016)... , Nov 15, 2016 Research and ... Global Forecast to 2021" report to their offering. ... ... USD 16.18 Billion by 2021 from USD 6.21 Billion in 2016, ... Growth of the bioinformatics market is driven by the ...
(Date:6/22/2016)... 2016   Acuant , the leading ... has partnered with RightCrowd ® to ... Management, Self-Service Kiosks and Continuous Workforce Assurance. ... functional enhancements to existing physical access control ... with an automated ID verification and authentication ...
(Date:6/15/2016)... York , June 15, 2016 ... new market report titled "Gesture Recognition Market by Application ... Forecast, 2016 - 2024". According to the report, the  ... 11.60 billion in 2015 and is estimated to ... USD 48.56 billion by 2024.  Increasing ...
Breaking Biology News(10 mins):